1443-9506 < 1444-0903 < 1445-1433

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by 1444-0903

Number of relevant bibliographic references: 24.

Ident.	Authors (with country if any)	Title
000F27 (2015)	L. Cummins [Australie] ; V. S. Katikireddi [Australie] ; S. Shankaranarayana [Australie] ; K. Y. C. Su [Australie] ; E. Duggan [Australie] ; V. Videm [Australie, Norvège] ; H. Pahau [Australie] ; R. Thomas [Australie]	Safety and retention of combination triple disease‐modifying anti‐rheumatic drugs in new‐onset rheumatoid arthritis
000F31 (2015)	F. Chen [République populaire de Chine] ; X. Lu [République populaire de Chine] ; X. Shu [République populaire de Chine] ; Q. Peng [République populaire de Chine] ; X. Tian [République populaire de Chine] ; G. Wang [République populaire de Chine]	Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study
000F44 (2015)	F. Aljuani [France] ; A. Tournadre [France] ; S. Cecchetti [France] ; M. Soubrier [France] ; J. J. Dubost [France]	Macro‐creatine kinase: a neglected cause of elevated creatine kinase
001250 (2013)		ASCIA 2013 Clinical Grand Rounds Abstracts
001326 (2012)	H. Ahmadzai ; M. C. Kiernan ; D. Wakefield [Australie] ; P. S. Thomas	Treatment of refractory neurosarcoidosis with TNF‐inhibitors: what lies ahead?
001348 (2012)	J. B. Sartain [Australie] ; N. L. Anderson [Australie] ; J. J. Barry ; P. T. Boyd ; P. W. Howat	Rheumatic heart disease in pregnancy: cardiac and obstetric outcomes
001358 (2012)	V. S. Katikireddi [Australie] ; D. A. Kandiah [Australie]	Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy
001371 (2012)	D. Tong [Australie] ; N. Manolios [Australie] ; G. Howe ; D. Spencer	New onset sarcoid‐like granulomatosis developing during anti‐TNF therapy: an under‐recognised complication
001517 (2011)	C. Domingo [Espagne, Canada] ; A. Moreno [Espagne] ; R. Mirapeix [Espagne]	Rationale for the use of immunomodulatory therapies in the Global Initiative for Asthma (GINA) step V asthma other than oral glucocorticosteroids
001553 (2011)	D. S. A. Mcleod ; M. L. Woods ; D. A. Kandiah [Australie]	Immune reconstitution inflammatory syndrome manifesting as development of multiple autoimmune disorders and skin cancer progression
001564 (2011)	K. Montag [Australie] ; M. Gingold [Australie] ; A. Boers [Australie] ; G. Littlejohn [Australie]	Disease‐modifying anti‐rheumatic drug usage, prescribing patterns and disease activity in rheumatoid arthritis patients in community‐based practice
001573 (2011)	M. Dugar [Australie] ; S. Cox ; V. Limaye ; P. Blumbergs ; P. J. Roberts-Thomson [Australie]	Clinical heterogeneity and prognostic features of South Australian patients with anti‐synthetase autoantibodies
001588 (2011)		ARA Scientific Posters
001680 (2010)	M. C. Kennedy [Australie]	Post‐mortem drug concentrations
001682 (2010)		Poster and Oral Abstracts
001689 (2010)	S. J. Butterly ; P. Pillans [Australie] ; B. Horn [Australie] ; R. Miles ; J. Sturtevant	Off‐label use of rituximab in a tertiary Queensland hospital
001848 (2009)	N. Varatharajan [Australie] ; I. G. S. Lim ; A. Anandacoomarasamy ; R. Russo ; K. Byth [Australie] ; D. G. Spencer ; N. Manolios ; G. B. Howe [Australie]	Methotrexate: long‐term safety and efficacy in an Australian consultant rheumatology practice
001C68 (2006)	S. W. Lim [Australie] ; D. Gillis [Australie] ; W. Smith [Australie] ; P. Hissaria [Australie] ; H. Greville [Australie] ; C. A. Peh [Australie]	Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports
001C84 (2006)	R. L. Savage [Australie, Nouvelle-Zélande] ; J. Highton [Australie] ; I. W. Boyd [Australie] ; P. Chapman [Australie]	Pneumonitis associated with leflunomide: a profile of New Zealand and Australian reports
001F35 (2004)	G. E. M. Reeves [Australie]	Update on the immunology, diagnosis and management of systemic lupus erythematosus
001F47 (2004)		Subject index
002024 (2004)		Abstracts presented at the Annual Scientific Meeting of the Australian Rheumatology Association and the Rheumatology Health Professionals Association, 2004
002193 (2002)		Proceedings of the 2001 Annual Scientific Meeting of the Australian Rheumatology Association with the Rheumatology Health Professionals Association
002347 (2001)	J. Alpers [Australie]	Papua and New Guinea medical experiences

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "1444-0903" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "1444-0903" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1444-0903
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021